NVIDIA Corporation (NVDA) vs West Pharmaceutical Services, Inc. (WST): Which Is the Better Buy in 2026?
As of 2026-06-21, NVDA is overvalued at $211, with a DCF intrinsic value of $163 and a margin of safety of -29%. WST is overvalued at $328, with an intrinsic value of $184 and a margin of safety of -78%. Of the two, NVDA has the wider margin of safety.
Rewards
- ★NVIDIA Corporation has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
- ★Gross margin of 74.1% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
- ★Free cash flow has grown at a 193.9% CAGR over the past 4 years, demonstrating strong earnings power growth.
- ★West Pharmaceutical Services, Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
- ★Altman Z-Score of 13.89 indicates very low bankruptcy risk — the company is firmly in the safe zone.
- ★Net debt/EBITDA of -0.2x means the company holds more cash than debt — a net cash position.
Risks
- ⚠FCF yield of 1.9% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
- ⚠Beneish M-Score of -1.06 flags financial patterns consistent with potential earnings manipulation — warrants further investigation.
- ⚠38 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.
- ⚠FCF yield of 2.0% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
- ⚠PEG ratio of 3.16 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
Key Valuation Metrics
Learn more →Historical Fundamentals
Learn more →Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.
Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.
Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.
$1 Retained Earnings Test
Learn more →> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
Discounted Cash Flow (DCF) Analysis
Learn more →Reverse DCF — Market-Implied Growth
Learn more →What growth rate is the market pricing in at $211?
The market implies +17.9% Owner Earnings growth, below historical trends — potential opportunity.
Standard FCF implies a more demanding +20.8%, reflecting heavy growth investment expected to generate future returns.
What growth rate is the market pricing in at $328?
The market implies +19.2% Owner Earnings growth, above historical trends.
Standard FCF implies a demanding +19.9%, reflecting heavy growth investment.
Economic Moat Score
Learn more →Narrow moat with roic consistency as the key competitive advantage. Improving revenue predictability would strengthen the moat.
Narrow moat with revenue predictability as the key competitive advantage. Improving margin stability would strengthen the moat.
Forensic Accounting
Learn more →M-Score Trend
M-Score Trend
Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
Ownership Breakdown
Learn more →High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.
Insider Buying Activity
Learn more →Open market purchases · includes direct & indirect ownership · excludes option exercises.
Insider Selling Activity
Learn more →Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.
🎭 Mr. Market's Mood
Learn more →"Market is pricing this stock without strong emotion in either direction"
"Market is optimistic — be cautious and ensure you have a margin of safety"
Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
⚖️ Buffett Signal
Learn more →The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.
The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.
Frequently Asked Questions: NVDA vs WST
Is NVIDIA Corporation or West Pharmaceutical Services, Inc. more undervalued in 2026?▼
Based on our discounted cash flow model, NVDA trades at a -29.0% margin of safety (intrinsic value $163 vs. price $211), compared to WST's -77.9% margin of safety (intrinsic $184 vs. $328).
Which stock has a wider economic moat, NVIDIA Corporation or West Pharmaceutical Services, Inc.?▼
NVDA scores 69/100 (Narrow moat), while WST scores 68/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.
Which company has better free cash flow, NVIDIA Corporation or West Pharmaceutical Services, Inc.?▼
West Pharmaceutical Services, Inc. (WST) generates a 2.0% free cash flow yield, compared to NVIDIA Corporation's 1.9%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.
Which stock has higher return on invested capital, NVIDIA Corporation or West Pharmaceutical Services, Inc.?▼
NVDA earns 63.1% ROIC versus WST's 16.7%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.
Which dividend is safer, NVIDIA Corporation's or West Pharmaceutical Services, Inc.'s?▼
WST's dividend earns a safety score of 94/100 (Very Safe), compared to NVDA's 91/100 (Very Safe). WST has raised its dividend for 3 consecutive years.
Does NVIDIA Corporation have accounting red flags?▼
NVDA's Beneish M-Score of -1.1 flags it as a likely earnings manipulator (above the -1.78 threshold). By contrast, WST scores -2.8, within the normal range. The Beneish model detects aggressive accounting through eight financial ratios.